Grants and Contributions:
Title:
Accelerating Antibody Modeling with AI: Speeding up In-Silico Drug Discovery
Agreement Number:
1024128
Agreement Value:
$500,000.00
Agreement Date:
Oct 17, 2024 - Jan 16, 2026
Description:
The firm will use machine learning to predict the 3D structure of antibodies more accurately and rapidly than existing technologies. A tool will be developed to provide antibody structures. The enhanced AI-enabled platform will be used to search and identify therapeutic antibodies.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H2X 2J1
Reference Number:
172-2024-2025-Q3-1024128
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
858257454
Recipient Type:
For-profit organization
Recipient's Legal Name:
Kisoji Biotechnologie Inc.
Federal Riding Name:
Ville-Marie--Le Sud-Ouest--Île-des-Soeurs
Federal Riding Number:
24077
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710